By Finance Pulse in KeyInfo —

FDA Approves Injectable Version of Opdivo by Bristol Myers Squibb

FDA greenlights injectable Opdivo, enhancing cancer treatment options. Bristol Myers Squibb's PD-1 inhibitor Opdivo gains approval, marking a healthcare innovation.

A sleek and modern illustration of a syringe with a backdrop of molecular structures, symbolizing in
FDA Approves Injectable Version of Opdivo by Bristol Myers Squibb

The U.S. FDA approved an injectable version of Bristol Myers Squibb's cancer drug, Opdivo, which is a PD-1 inhibitor.

Source